Kyle W. Gano

2018

In 2018, Kyle W. Gano earned a total compensation of $4.6M as Chief Business Development Officer at Neurocrine Biosciences, a 94% increase compared to previous year.

Compensation breakdown

Bonus$191,473
Option Awards$1,309,024
Salary$403,100
Stock Awards$2,656,575
Other$8,069
Total$4,568,241

Gano received $2.7M in stock awards, accounting for 58% of the total pay in 2018.

Gano also received $191.5K in bonus, $1.3M in option awards, $403.1K in salary and $8.1K in other compensation.

Rankings

In 2018, Kyle W. Gano's compensation ranked 2,297th out of 14,244 executives tracked by ExecPay. In other words, Gano earned more than 83.9% of executives.

ClassificationRankingPercentile
All
2,297
out of 14,244
84th
Division
Manufacturing
839
out of 5,762
85th
Major group
Chemicals And Allied Products
281
out of 2,125
87th
Industry group
Drugs
226
out of 1,814
88th
Industry
Biological Products, Except Diagnostic Substances
47
out of 339
86th

Pay ratio

Kyle W. Gano's Pay$4,568,241
Median Employee's Pay$259,000
Pay Ratio

18

to 1

In 2018, the annual total compensation of Kyle W. Gano was $4,568,241.

The annual total compensation of the median employee at Neurocrine Biosciences was $259,000.

The ratio of Kyle W. Gano's pay to the pay of median employee was therefore 18 to one.

Source: SEC filing on April 17, 2019.

Gano's colleagues

We found five more compensation records of executives who worked with Kyle W. Gano at Neurocrine Biosciences in 2018.

2018

Kevin Gorman

Neurocrine Biosciences

Chief Executive Officer

2018

Eiry Roberts

Neurocrine Biosciences

Chief Medical Officer

2018

Eric Benevich

Neurocrine Biosciences

Chief Commercial Officer

2018

Haig Bozigian

Neurocrine Biosciences

Chief Development Officer

2018

Matthew Abernethy

Neurocrine Biosciences

Chief Financial Officer

News

You may also like